Time-related adaptations in plasma neurohormone levels and hemodynamics after myocardial infarction in the rat

Journal of Cardiac Failure

Volumn 4, Issue 2, 1998, Pages 131-138

  Ceiler, Debbie L ^a,b   Schiffers, Paul M H ^a   Nelissen Vrancken, H J Marjorie G ^a   Smits, Jos F M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Hemodynamics; Myocardial infarction; Neurohormones; Rat

Indexed keywords

ADRENALIN; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN; NEUROHORMONE; NORADRENALIN;

ACUTE HEART INFARCTION; ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NEUROENDOCRINOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

EID: 0031875127     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(98)90254-8     Document Type: Article

References (44)

1. Erikkson H: Heart failure: a growing public health problem. J Intern Med 1195;237:135-41
2. Teerlink JR: Neurohormonal mechanisms in heart failure: a central role for the renin-angiotensin system. J Cardiovasc Pharmacol 1996;27(Suppl 2):S1-8
3. Packer M: The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-54
4. Sigurdsson A, Held P, Swedberg K: Short- and long-term neurohormonal activation following acute myocardial infarction. Am Heart J 1993;126:1068-76
5. Rouleau JL, Moyé LA, de Champlain J, Klein M, Bichet D, Packer M, Dagenais G, Sussex B, Arnold JM, Sestier F, Parker JO, McEwan MMP, Bernstein V, Cuddy TE, Delage F, Nadeau C, Lamas GA, Gottlieb SS, McCans J, Pfeffer MA: Activation of neurohormonal systems following acute myocardial infarction. Am J Cardiol 1991;68: 80D-6D
6. Rouleau JL, Packer M, Moyé L, de Champlain J, Bichet D, Klein M, Rouleau JR, Sussex B, Arnold JM, Sestier F, Parker JO, McEwan P, Bernstein V, Cuddy TE, Lamas G, Gottlieb SS, McCans J, Nadeau C, Delage F, Wun CCC, Pfeffer MA: Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 1994;24:390-8
7. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C-S, Kubo SH, Rudin-Toretsky E, Yusuf S, for the SOLVD Investigators: Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9
8. Swedberg K, Eneroth P, Kjekhus J, Wilhelmsen L, for the CONSENSUS Trial Study Group: Hormones regulating cardiovascular function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1990;82:1730-6
9. Svengaard J, Angelo-Nielsen K, Pindborg T: Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. Br Heart J 1992;68:38-42
10. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23
11. Swedberg K, Eneroth P, Kjekshus J, Snapinn S, for the CONSENSUS Trial Study Group: Effect of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). Am J Cardiol 1990;66:40D-5D
12. The CONSENSUS trial study group: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandanavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35
13. Schoemaker RG, Urquhart J, Debets JJM, Struijker Boudier HAJ, Smits JFM: Acute hemodynamic effects of coronary artery ligation in conscious rats. Basic Res Cardiol 1990;85:9-20
14. Drexler H, Toggart EJ, Glick MR, Heald J, Flaim SF, Zelis R: Regional vascular adjustments during recovery from myocardial infarction in rats. J Am Coll Cardiol 1986;8: 134-42
15. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Koner RA, Braunwald E: Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12
16. Schoemaker RG, Debets JJM, Struijker Boudier HAJ, Smits JFM: Beneficial hemodynamics effects of two weeks' milrinone treatment in conscious rats with heart failure. Eur J Pharmacol 1990;182:527-35
17. Luchner A, Stevens TL, Borgeson DD, Redfield MM, Bailey JE, Sandberg SM, Heublein DM, Burnett JJC: Angiotensin II in the evolution of experimental heart failure. Hypertension 1996;28:472-7
18. Mulder P, Richard V, Derumeaux GH M, Henry JP, Lallemand F, Compagnon P, Mace B, Comoy E, Letac B, Thuillez C: Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 1997;96:1976-82
19. Lee RW, Gay RG, Moffet C, Johnson DG, Goldman S: Atrial natriuretic peptide levels during development of chronic heart failure after myocardial infarction in rats. Life Sci 1987;40:2025-30
20. Bélichard P, Savard P, Cardinal R, Nadeau R, Gosselin H, Paradis P, Rouleau JL: Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrythmias. J Am Coll Cardiol 1994;23:505-13
21. Hodsman GP, Kohzuki M, Howes LG, Sumithran E, Tsunoda K, Johnston CI: Neurohormonal responses to chronic myocardial infarction in rats. Circulation 1988;78: 376-81
22. Vanveldhuisen DJ, Vangilst WH, Desmet BJGL, Degraeff PA, Scholtens E, Buikema H, Girbes ARJ, Wesseling H, Lie KI: Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure. Cardiovasc Drugs Ther 1994;8:245-50
23. Schoemaker RG, Debets JJM, Struijker Boudier HAJ, Smits JFM: Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol 1991;23:187-97
24. Smits JFM, Coleman TG, Smith TL, Kasbergen CM, van Essen H, Struijker Boudier HAJ: Antihypertensive effect of propanolol in conscious spontaneously hypertensive rats: central hemodynamics, plasma volume and renal function during beta-blockade with propanolol. J Cardiovasc Pharmacol 1982;4:903-14
25. Smith TL, Hutchins PM: Central hemodynamics in the developmental stage of spontaneous hypertension in the unanesthetized rat. Hypertension 1979;1:508-17
26. Stassen FRM, Willemsen MJJMF, Janssen GMJ, Fazzi GE, Schiffers PMH, Smits JFM, De Mey JGR: Reduced responsiveness of rat mesenteric artery smooth muscle to phenylephrine and calcium following myocardial infarction. Br J Pharmacol 1997;120:1506-12
27. van der Hoorn FA, Boomsma F, Man-in-'t-Veld AJ, Schalekamp MA: Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescent detection and an established method with electrochemical detection. J Chromatogr 1989;487:17-28
28. van Krimpen C, Smits JFM, Cleutjens JPM, Debets JJM, Schoemaker RG, Struijker Boudier HAJ, Bosman FT, Daemen MJAP: DNA synthesis in the noninfarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991;23:1245-53
29. Passier RCJJ, Smits JFM, Verluyten MJA, Studér R, Drexler H, Daemen MJAP: Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 1995;269:H1268-76
30. Smits JFM, Passier RCJJ, Nelissen-Vrancken HJMG, Kuizinga MC, Daemen MJAP: Does ACE inhibition limit structural changes in the heart following myocardial infarction? Eur Heart J 1995;16(Suppl N):46-51
31. Kobayashi M, Furukawa Y, Chiba S: Positive chrontropic and inotropic effects of angiotensin II in the dog heart. Eur J Pharmacol 1978;50:17-25
32. Shen Y-T, Graham RM, Vatmer SF: Effects of atrial natriuretic factor on blood flow distribution and vascular resistance in conscious dogs. Am J Physiol 1991;260: H1893-902
33. Battistini B, D'Orleans-Juste P, Sirois P: Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993;68:600-28
34. Dzau VJ, Pratt R, Gibbons GH: Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease. Drugs 1994;47:1-13
35. Pinto YM, Buikema H, van Gilst WH: Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses. Clin Exp Hypertens 1995;17:441-68
36. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y: Interactions between endothelium-derived relaxing factors in health and cardiovascular disease. Circulation 1993; 87(Suppl 5):V36-44
37. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-72
38. Gaudron P, Eiles C, Ertl G, Kochsiek K: Adaptation to cardiac dysfunction after myocardial infarction. Circulation 1993;87(Suppl 4):IV83-9
39. Grossman W, Jones D, McLaurin LD: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64
40. Baker KM, Chernin MI, Wixson SK, Aceto JF: Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990;259: H324-32
41. Anversa P, Beghi C, Kikkawa Y, Olivetti G: Myocardial response to infarction in the rat: morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Pathol 1985;118:484-92
42. Vatner SF, Shannon R, Hittinger L: Reduced subendocardial coronary reserve: a potential mechanism for impaired diastolic function in the hypertrophied and failing heart. Circulation 1990;81(Suppl 2):III8-14
43. Heeneman S, Leenders PJA, Aarts PJJW, Smits JFM, Arends JW, Daemen MJAP: Peripheral vascular alterations during experimental heart failure in the rat: do they exist? Arterioscler Thromb Vasc Biol 1995;15:1503-11
44. Pfeffer JM, Fischer TA, Pfeffer MA: Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 1995;57: 805-26